Application 218364
- Type
- ANDA
- Sponsor
- MYLAN LABS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 500MG/100ML (5MG/ML) | No | No |
| 002 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 1GM/100ML (10MG/ML) | No | No |
| 003 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 1.5GM/100ML (15MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218364-001 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | 500MG/100ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | |
| A218364-002 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | 1GM/100ML (10MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | |
| A218364-003 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | 1.5GM/100ML (15MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218364-001 | AP |
| A218364-002 | AP |
| A218364-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A218364-001 | LEVETIRACETAM IN SODIUM CHLORIDE | 500MG/100ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A218364-002 | LEVETIRACETAM IN SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A218364-003 | LEVETIRACETAM IN SODIUM CHLORIDE | 1.5GM/100ML (15MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A218364-001 | LEVETIRACETAM IN SODIUM CHLORIDE | 500MG/100ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A218364-002 | LEVETIRACETAM IN SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A218364-003 | LEVETIRACETAM IN SODIUM CHLORIDE | 1.5GM/100ML (15MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A218364-001 | LEVETIRACETAM IN SODIUM CHLORIDE | 500MG/100ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A218364-002 | LEVETIRACETAM IN SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A218364-003 | LEVETIRACETAM IN SODIUM CHLORIDE | 1.5GM/100ML (15MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A218364-001 | LEVETIRACETAM IN SODIUM CHLORIDE | 500MG/100ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A218364-002 | LEVETIRACETAM IN SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A218364-003 | LEVETIRACETAM IN SODIUM CHLORIDE | 1.5GM/100ML (15MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-001 | LEVETIRACETAM IN SODIUM CHLORIDE | 500MG/100ML (5MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-002 | LEVETIRACETAM IN SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-003 | LEVETIRACETAM IN SODIUM CHLORIDE | 1.5GM/100ML (15MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2026-05-08 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A218364-001 | AP | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A218364-002 | AP | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A218364-003 | AP | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A218364-001 | AP | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A218364-002 | AP | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A218364-003 | AP | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A218364-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A218364-002 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A218364-003 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A218364-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A218364-002 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A218364-003 | AP | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-001 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-002 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218364-003 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levetiracetam | LEVETIRACETAM | REMEDYREPACK INC. | 46852061-e59a-4a8c-aba0-ce4c7887f366 | 2026-11-06 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | PD-Rx Pharmaceuticals, Inc. | c2177034-e164-453c-be02-1cf91ce27a07 | 2026-11-05 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Civica, Inc. | 1591c690-f4ed-44b7-a9d0-bff1fbb4bfef | 2026-11-03 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Direct_Rx | 5f10cab7-afa3-2435-e063-6394a90afd75 | 2026-10-30 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam Levetiracetam | LEVETIRACETAM | Atlantic Biologicals Corp. | 56fed03f-38c3-4273-8fd7-522bc508bf36 | 2026-10-23 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Major Pharmaceuticals | c4b27429-50a3-467c-a5ff-7e49a01a1088 | 2026-10-20 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | PD-Rx Pharmaceuticals, Inc. | 792db8dc-177b-4864-8600-12823819082d | 2026-10-15 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | REMEDYREPACK INC. | 94d042f7-93b9-43bd-9ace-cfc61903b4d7 | 2026-10-14 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | REMEDYREPACK INC. | 74ccc9f1-b957-4b1b-9464-1b5e3318c916 | 2026-10-14 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Granules Pharmaceuticals Inc. | b4781ec4-43ad-4052-9a6a-b24fda119b32 | 2026-10-08 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam Extended-Release | LEVETIRACETAM | Golden State Medical Supply, Inc. | 5dde1889-a217-4493-9a71-9fd39ed04630 | 2026-09-30 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Aurobindo Pharma Limited | f65ec19d-b90e-452e-b761-c68b1cf2c892 | 2026-09-22 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Apotex Corp. | abc9fada-c5c2-4e07-fb8a-4d1518f7657e | 2026-09-14 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Cardinal Health 107, LLC | 100d7618-b8e6-43f5-a4e2-6fd728de9d3f | 2026-09-11 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | XGen Pharmaceuticals DJB, Inc. | 8bf7c1ce-dfc4-457f-8a8b-365f82aa8512 | 2026-09-09 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Cardinal Health 107, LLC | 0348fec4-d919-4307-ac90-35360819bc00 | 2026-09-04 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | REMEDYREPACK INC. | 2d307850-0ed5-4f32-ac62-0e1e2fe27a7a | 2026-09-03 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam ER | LEVETIRACETAM | REMEDYREPACK INC. | 2d57f22f-fecc-466e-a444-87708c7c2f80 | 2026-08-27 | Warnings, Adverse reactions | LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Direct_Rx | 5517b148-1eff-6421-e063-6394a90a9498 | 2026-08-27 | Warnings, Adverse reactions | LEVETIRACETAM |
| LEVETIRACETAM | LEVETIRACETAM | REMEDYREPACK INC. | 9bdef24b-c50e-4e6a-8650-59d78009f472 | 2026-08-26 | Warnings, Adverse reactions | LEVETIRACETAM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.